Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
about
Understanding and Managing Pregnancy in Patients with LupusManagement of urticaria: not too complicated, not too simpleExposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases.Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to knowThe motherhood choices decision aid for women with rheumatoid arthritis increases knowledge and reduces decisional conflict: a randomized controlled trialAre monoclonal antibodies a safe treatment for cancer during pregnancy?Effects of fetal exposure to maternal chemotherapy.Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy.Diagnosis, pathogenesis and treatment of myositis: recent advances.Current immunotherapy in rheumatoid arthritis.Safety and tolerability of tumor necrosis factor-α inhibitors in psoriasis: a narrative review.Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management.Safety of anti-rheumatic drugs for rheumatoid arthritis in pregnancy and lactation.The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure.Ceruloplasmin decreases respiratory burst reaction during pregnancy.Successful pregnancy in the context of previously undiagnosed chronic lymphocytic leukaemia: A case report and literature review.New onset pemphigus foliaceus during pregnancy: A rare case.Chronic pain during pregnancy: a review of the literature.
P2860
Q26798179-BA3806E0-1CB6-4826-ABE1-C5CDC7875091Q26828373-BC87AF46-A06F-45E3-A9F2-818317A5D28DQ33405115-2A59F913-5118-4363-8062-4C65CC011658Q34389362-A90F01D3-3B80-4931-A467-60D1E3217C21Q35784253-70AF1591-9FE5-4822-8520-5FC1DD50E3B9Q38119550-07D2B488-0CD4-4A2E-89F9-0DD25DD183D3Q38121738-0FE64099-B844-4D1C-AA99-5424A82DE431Q38126540-7982B93C-26B4-4FB2-A772-DA277A9B8144Q38131849-7ECCA2DF-5CD4-400D-AABB-64C2590F470BQ38133655-F5AD2DEA-E1CD-4951-A682-611D9B93F7EFQ38166663-AEEB3352-58E1-4A54-8654-91AF8B2F50B6Q38254406-DBBA101E-C0A9-452A-B8F0-196C13A642DFQ38820088-27E779F8-23DC-4990-A320-0C68A19895D5Q39165767-E84F646E-7E66-4D57-AD53-616A29A4FC73Q39707068-367957F1-592A-4172-9BC6-5B7564B3D9B4Q46300935-15A17C33-BD56-4480-A2A1-E0EC69C9BA91Q55047463-78DE3993-454A-4C8C-9321-AB33E95B5A47Q55054322-948079D6-2F8E-432C-831C-CF18E7697318
P2860
Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
@en
Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
@nl
type
label
Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
@en
Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
@nl
prefLabel
Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
@en
Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
@nl
P2093
P2860
P1433
P1476
Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
@en
P2093
Ashima Makol
Kerry Wright
Shreyasee Amin
P2860
P304
P356
10.2165/11596240-000000000-00000
P577
2011-10-01T00:00:00Z
P6179
1030921057